This provider averages 98 services per working day
Based on 243.9K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $31.3M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Averaging 98 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $231.41 | $125.39 | 1.85x | $106.02 | $3.1M | 24.5K | 23 |
| 2015 | $250.27 | $135.59 | 1.85x | $114.68 | $3.7M | 27.5K | 24 |
| 2016 | $249.51 | $124.96 | 2.00x | $124.55 | $3.3M | 26.3K | 24 |
| 2017 | $254.52 | $125.58 | 2.03x | $128.94 | $3.0M | 23.8K | 23 |
| 2018 | $288.23 | $140.06 | 2.06x | $148.17 | $3.1M | 22.2K | 23 |
| 2019 | $294.39 | $142.10 | 2.07x | $152.29 | $3.1M | 21.9K | 22 |
| 2020 | $308.89 | $152.21 | 2.03x | $156.68 | $2.5M | 16.3K | 19 |
| 2021 | $324.47 | $160.09 | 2.03x | $164.38 | $3.0M | 18.5K | 22 |
| 2022 | $296.56 | $145.23 | 2.04x | $151.33 | $3.2M | 21.7K | 23 |
| 2023 | $170.04 | $83.09 | 2.05x | $86.95 | $3.4M | 41.3K | 24 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | 36.7K | $10.2M | $278.96 | 1.80x |
| J0178 | Injection, aflibercept, 1 mg | 13.5K | $10.0M | $743.27 | 1.68x |
| 92014 | Established patient complete exam of visual system | 24.1K | $2.1M | $87.05 | 2.82x |
| 67028 | Injection of drug into eye | 23.6K | $2.0M | $85.53 | 2.71x |
| 92134 | Imaging of retina | 33.0K | $1.0M | $30.96 | 2.96x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 29.2K | $854.3K | $29.23 | 1.44x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 6.9K | $629.9K | $90.95 | 2.42x |
| J7999 | Compounded drug, not otherwise classified | 9.2K | $610.8K | $66.29 | 1.49x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 3.1K | $484.5K | $157.65 | 1.64x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 5.1K | $408.1K | $80.04 | 2.54x |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 1.6K | $396.1K | $250.98 | 1.59x |
| J3490 | Unclassified drugs | 365 | $377.1K | $1.0K | 2.05x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 3.1K | $343.7K | $112.24 | 2.81x |
| 92250 | Photography of the retina | 6.5K | $305.8K | $47.38 | 2.96x |
| 92226 | Examination of eye by ophthalmoscope with retinal drawing | 12.2K | $219.4K | $17.98 | 2.82x |
| 67042 | Removal of membrane from the retina, pars plana approach with removal of internal limiting membrane of retina | 196 | $182.7K | $932.00 | 2.62x |
| 92012 | Established patient problem focused exam of visual system | 2.7K | $169.2K | $61.81 | 2.85x |
| 92225 | Examination of eye by ophthalmoscope with retinal drawing | 8.4K | $169.1K | $20.16 | 2.84x |
| 92004 | New patient complete exam of visual system | 1.3K | $131.7K | $99.71 | 2.96x |
| J3396 | Injection, verteporfin, 0.1 mg | 15.2K | $127.6K | $8.42 | 1.62x |
This provider submits charges 2 times higher than what Medicare actually pays.
A markup ratio of 2x means for every $100 Medicare pays, this provider initially charges $200. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in AZ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Derek Kunimoto, MD | Mesa, AZ | $68.3M | ✓ Clear |
| David Goldenberg, MD | Phoenix, AZ | $50.8M | ✓ Clear |
| Sachin Mehta, M.D. | Phoenix, AZ | $43.3M | ✓ Clear |
| Edward Quinlan, M.D. | Phoenix, AZ | $40.1M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data